Scorecard: 2/4 — two holds, two flips on a wild Thursday

Thursday's five-feature edition finished 2/4 on direction: the two news-driven calls held, while momentum reads whipsawed. Liquidia faded its settlement spike and Rocket Lab stayed red on the Neutron delay; Greenland Energy gave back its 76% rip and CoreWeave reversed violently.

In this brief: 4 sections 2 min read

- $380.7M United Therapeutics settlement kept Yutrepia on market; BTIG upgraded to Buy with a $70 target
- Up ~26% in early Thursday trading, then sold off nearly the whole spike into the close
- Still green at the bell = directionally correct; classic news fade
- Wednesday's +76% close on the US-Denmark-Greenland pact was the whole move
- Thursday opened flat at $3.90 and faded all session; intraday down as much as ~16-19%
- Pre-revenue explorer on 20x volume — momentum trades need follow-through
- Maiden Neutron flight pushed from Q4 2026 to 2027 on a carbon-composite dome defect
- Fell as much as 16% intraday; KeyBanc cut its target to $100, Clear Street to $105
- Recovered from the lows but stayed red all session — correct directional call
- Down ~5-6% premarket after Wednesday's -15% plunge on leverage fears
- Fears reversed midday — closed +5.9% at ~$69.69 in a violent whipsaw
- Reminder: continuation reads on momentum names can flip violently

Useful?